explore -WSS

explore

author：fashion 2025-09-28 21:05:40 - browse：437

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： It's time to retire 'poor historian' from clinicians' vocabularies

WSS

Venture capitalist Bob Kocher on the state of digital health

Eli Lilly’s Mounjaro succeeds in second weight

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Can medical device makers keep up in the race to treat obesity?

Millions may soon lose Medicaid when they don't have to

focus

explore

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Cancer drug shortages should be causing more outrage

Venture capitalist Bob Kocher on the state of digital health

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Criminal prosecution for violating HIPAA: an emerging threat

Moonlake's readout produced a cash windfall. Risks remain

Venture capitalist Bob Kocher on the state of digital health

Moonlake's readout produced a cash windfall. Risks remain

Cytokinetics CEO stresses company can launch heart drug on its own

explore

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Solving academic medical centers' existential crisis

Venture capitalist Bob Kocher on the state of digital health

The thinking behind the controversial eating disorder chatbot Tessa

Sea level rise could wash away turtle breeding grounds around the world, researchers say

hotspot

focus

focus

Wikipedia